Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Abstract Background Erythrocytes are a major source of peripheral α-synuclein (α-Syn). The goal of the current investigation is to evaluate erythrocytic total, oligomeric/aggregated, and phosphorylated α-Syn species as biomarkers of Parkinson’s disease (PD). PD and healthy control blood samples were...
Main Authors: | Chen Tian, Genliang Liu, Liyan Gao, David Soltys, Catherine Pan, Tessandra Stewart, Min Shi, Zhiying Xie, Na Liu, Tao Feng, Jing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40035-019-0155-y |
Similar Items
-
Erythrocytic α-Synuclein Species for Parkinson’s Disease Diagnosis and the Correlations With Clinical Characteristics
by: Zhenwei Yu, et al.
Published: (2022-02-01) -
Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
by: Zhenwei Yu, et al.
Published: (2023-08-01) -
Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease
by: Yuanchu Zheng, et al.
Published: (2022-03-01) -
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
by: Xiaodan Liu, et al.
Published: (2021-03-01) -
Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
by: Na Li, et al.
Published: (2020-09-01)